Research and Development

Showing 15 posts of 9599 posts found.

Frazier Healthcare Acquires U.S. Commercial Pharmaceutical Packaging Operations from Catalent Pharma Solutions

June 21, 2012 Manufacturing and Production, Research and Development

Seattle, Wash., and Somerset N.J., (June 20, 2012)  — Frazier Healthcare and Catalent Pharma Solutions, Inc., today announced they have closed …
juliastrakerpress-11

New head of strategic planning for PAN advertising

June 21, 2012 Business Services, Medical Communications, Research and Development, Sales and Marketing Indigenus, Med Comms, Pan Advertising, appointment

Julia Straker has been appointed head of strategic planning at medical communciations agency PAN Advertising.  Julia joins from TBWA\Paling Walters …

Sanofi joins forces with Joslin Diabetes Center

June 21, 2012 Research and Development, Sales and Marketing

Sanofi and the Joslin Diabetes Center have created a new partnership to develop diabetes medicines. The collaboration will focus on …

Contract research news in brief

June 20, 2012 Research and Development Analytical Solutions Inc, Metanomics Health, PMG Research, Quintiles, Scripps Research Institute, Tergus Pharma

Quintiles sets up Chinese HQ, plus updates from BMS/Scripps, Metanomics Health, Inclinix/PMG and Tergus Pharma.
EMA HQ

EMA clarifies antibodies development

June 20, 2012 Manufacturing and Production, Research and Development, Sales and Marketing CMPHU, EMA, RA, antibodies

European regulators have issued final guidance on how pharma manufacturers should develop drugs containing monoclonal antibodies. Typically used in treatments …

Merck KGaA confirms leadership team appointments

June 20, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMD Serono, Merck KGaA, Serono

The subsidiary of Merck KGaA named EMD Serono has announced several appointments to its leadership team. The appointments include: Allene …
Roche image

Roche signs research deal on autism spectrum disorders

June 19, 2012 Research and Development, Sales and Marketing ASD, FXS, Roche, Seaside Therapeutics, asperger's, autism

Roche has signed an agreement with Seaside Therapeutics to develop new treatments for autism and other neurodevelopmental conditions such as …

Senates and networks – do they have a role in the new NHS?

June 19, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, health forum, reforms, senates and networks

The recent Westminster Health Forum meeting on ‘Developing Clinical Senates and Networks’ focused on one aspect of the new NHS …

Cmed Clinical Services showcases new in-house drug development consulting, regulatory and Medical Affairs group at DIA 2012

June 19, 2012 Research and Development

HORSHAM, UK — June 18, 2012 – Cmed Clinical Services, the global CRO specialised in the design and delivery of …
Pfizer image

FDA holds up Pfizer’s rare disease drug tafamidis

June 19, 2012 Research and Development, Sales and Marketing FDA, Pfizer, rare disease, tafamidis

The FDA has sent Pfizer a Complete Response Letter about its rare disease drug tafamidis meglumine. The US regulator is …

GSK partners with Cambridge University

June 18, 2012 Research and Development, Sales and Marketing ABPI, Cambridge, GSK, R&D

The University of Cambridge begins a new collaboration with GlaxoSmithKline today to advance drug discovery and the development of new …
Merck image

Merck’s sleep aid drug meets goals

June 15, 2012 Research and Development, Sales and Marketing FDA, Merck, insomnia, sleep disorder, suvorexant

Merck’s novel insomnia drug suvorexant has improved patients’ ability to fall asleep, according to new data from two Phase III …
Deepak Khanna

UK drug pricing: ABPI wants evolution, not revolution

June 14, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Deepak Khanna, MSD, PPRS, VBP, pricing

 As the ABPI prepares to negotiate a new pricing scheme for the first time in 50 years, its new president …

New chair of Health Research Authority confirmed by DH

June 14, 2012 Medical Communications, Research and Development, Sales and Marketing

Professor Jonathan Montgomery will head up the Health Research Authority, the new organisation that will protect and promote the interests …
sanofi website

Positive data for Sanofi’s diabetes drug

June 13, 2012 Research and Development, Sales and Marketing Lyxumia, Novo Nordisk, Sanofi, Victoza, diabetes

Sanofi’s new diabetes treatment Lyxumia has significantly reduced glycated hemoglobin (HbA1c) in two late-stage trials, the manufacturer says. Paris-based Sanofi …
The Gateway to Local Adoption Series

Latest content